CDK9 and cardiac hypertrophy: Indeed, although pharmacological CDK9 inhibition has been proposed as a therapy for abrogating cardiac hypertrophy (Krystof et al., 2010), the possibility of enhancing CDK9 activity has been overlooked as a mechanism that could be used to induce cardiac hypertrophy and to stimulate cardiomyocyte proliferation.